Skip to main content

Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT.

Interested parties may participate in the call by dialing:

(877) 407-6176 (US Toll-Free)

+1 (201) 689-8451 (International)

Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=4jnXGdPH

Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at www.viemed.com.

For further information, please contact:

Investor Relations
ir@viemed.com

Tripp Sullivan
SCR Partners, LLC
615-942-7077

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
337-504-3802

SOURCE: Viemed Healthcare, Inc.



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.11
-2.67 (-1.15%)
AAPL  276.07
-2.70 (-0.97%)
AMD  213.31
-8.11 (-3.66%)
BAC  54.19
+0.11 (0.20%)
GOOG  315.95
-5.05 (-1.57%)
META  646.89
-3.24 (-0.50%)
MSFT  479.37
+0.81 (0.17%)
NVDA  177.12
-6.66 (-3.62%)
ORCL  191.11
-31.90 (-14.30%)
TSLA  442.15
-9.30 (-2.06%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.